Propynoic Acid Ethyl Ester

Propynoic Acid Ethyl Ester

SCHEMBL6636396

C#CC(=O)OCC.[KH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1102766-B1 TRIAZOLOPYRIDINES FOR THE TREATMENT OF THROMBOSIS DISORDERS ORTHO MCNEIL PHARM INC (US) 2004-03-31 EP disclosed
US-6303625-B1 FIBRINOGEN RECEPTOR ANTAGONISTS WHICH INHIBIT PLATELET AGGREGATION AND ARE USEFUL IN TREATING THROMBOTIC DISORDERS ORTHO-MCNEIL PHARMACEUTICAL, INC. 2001-10-16 US disclosed
EP-1102766-A1 TRIAZOLOPYRIDINES FOR THE TREATMENT OF THROMBOSIS DISORDERS Ortho-McNeil Pharmaceutical, Inc. (US) 2001-05-30 EP disclosed
US-6191145-B1 ANTICOAGULANTS; ANTIINFLAMMATORY AGENTS ORTHO-MCNEIL PHARMACEUTICAL, INC. 2001-02-20 US disclosed
EP-1028943-A2 ORALLY-ACTIVE NIPECOTAMIDE GLYCOLAMIDE ESTERS FOR THE TREATMENT OF THROMBOSIS DISORDERS Ortho-Mcneil Pharmaceutical, Inc. (US) 2000-08-23 EP disclosed
US-6066651-A ANTITHROMBOTIC AGENTS BY VIRTUE OF THEIR ABILITY TO PREVENT PLATELET AGGREGATION ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2000-05-23 US disclosed
WO-2000006570-A1 TRIAZOLOPYRIDINES FOR THE TREATMENT OF THROMBOSIS DISORDERS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2000-02-10 WO disclosed
WO-1999021832-A2 ORALLY-ACTIVE NIPECOTAMIDE GLYCOLAMIDE ESTERS FOR THE TREATMENT OF THROMBOSIS DISORDERS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 1999-05-06 WO disclosed